Israel’s Gamida Cell Ltd. reported success in the Phase III clinical trial of its StemEx treatment for leukemia and lymphoma. Compared to a control group, far more patients receiving StemEx survived 100 days or more following transplantation.
http://www.gamida-cell.com/press_item.asp?ID=53
Israeli stem cells slow down blood cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.